Abstract:Technological and computational advances in genomics and interactomics have made it possible to identify rapidly how disease mutations perturb interaction networks within human cells. In this study, we investigate at large-scale the effects of network perturbations caused by disease mutations within the human three-dimensional (3D), structurally-resolved macromolecular interactome. We show that disease-associated germline mutations are significantly enriched in sequences encoding protein-protein interfaces compared to mutations identified in healthy subjects from the 1000 Genomes and ExAC projects; these interface mutations correspond to protein-protein interaction (PPI)-perturbing alleles including p.Ser127Arg in PCSK9 at the PCSK9-LDLR interface. In addition, somatic missense mutations are significantly enriched in PPI interfaces compared to non-interfaces in 10,861 human exomes across 33 cancer subtypes/types from The Cancer Genome Atlas. Using a binomial statistical model, we computationally identified 470 PPIs harboring a statistically significant excess number of missense mutations at protein-protein interfaces (termed putative oncoPPIs) in pan-cancer analysis. We demonstrate that the oncoPPIs, including histone H4 complex in individual cancer types, are highly correlated with patient survival and drug resistance/sensitivity in human cancer cell lines and patient-derived xenografts. We experimentally validate the network effects of 13 oncoPPIs using a systematic binary interaction assay. We further showed that ALOX5 p.Met146Lys at the ALOX5-MAD1L1 interface and RXRA p.Ser427Phe at the RXRA-PPARG interface promote significant tumor cell growth using cell line-based functional assays, providing a functional proof-of-concept. In summary, if broadly applied, this human 3D interactome network analysis offers a powerful tool for prioritizing alleles with mutations altering PPIs that may contribute to the pathobiology of human diseases, and may offer disease-specific targets for genotype-informed therapeutic discovery.

Discovery and significance of protein-protein interactions in health and disease

Advances of study of protein-protein interactions

Protein-protein interaction networks as miners of biological discovery

Studying protein-protein interactions: Latest and most popular approaches

Proteomic dissection of biological pathways/processes through profiling protein-protein interaction networks

Comprehensive characterization of protein–protein interactions perturbed by disease mutations

Detecting Protein Function and Protein-Protein Interactions from Genome Sequences

Uncovering organizing principles of protein-protein interaction networks

Interactomics: Toward Protein Function and Regulation

Mapping protein–protein interactions by mass spectrometry

Illuminating the Dark Protein-Protein Interactome

Mass spectrometry‐based protein–protein interaction networks for the study of human diseases

Dynamics of the discovery process of protein-protein interactions from low content studies

Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

Chemical and Biological Strategies for Profiling Protein-Protein Interactions in Living Cells.

Computational analyses of high-throughput protein-protein interaction data.

Multi-level bioinformatics resources support drug target discovery of protein-protein interactions

Comprehensive Characterization of Protein-Protein Interaction Network Perturbations by Human Disease Mutations

Analysis of Protein–Protein Functional Associations by Using Gene Ontology and KEGG Pathway

Progress in mass spectrometry approaches to profiling protein-protein interactions in the studies of the innate immune system

Identification of Protein–Protein Interaction Associated Functions Based on Gene Ontology